Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Determine which cash back credit card suits you best. Understand your spending habits to choose the right card for maximum rewards.
26,137 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
New SSA data show most retirees start Social Security before age 70, missing the strongest move that could boost life...
A fresh institutional stake in PENN Entertainment signals shifting sentiment in a dynamic gaming landscape. This deep...
Savers face a fast-moving market where finding best high-yield savings requires careful rate shopping. This report br...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Two well-positioned tech companies could be the catalysts for a multi-year fortune-building journey. This guide break...
When Gartner stock sagged today, traders weighed a price-target cut and the broader tech sentiment. This article brea...
Celsius Holdings has fallen hard, leaving some investors wondering if a rebound is possible. This guide breaks down t...
Investors are weighing Alibaba's AI and cloud ambitions against profits and regulatory headwinds. This guide breaks d...
Broadcom faces a fast-changing AI compute cycle that could lift shares toward $630, backed by custom silicon demand a...
Nike faces a pivotal earnings moment as June 30 approaches. This guide breaks down whether you should nike stock befo...